What does anti-Müllerian hormone (AMH) measure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Anti-Müllerian Hormone Measures

Anti-Müllerian hormone (AMH) measures ovarian reserve by reflecting the number of pre-antral and small antral follicles present in the ovaries, serving as a biomarker for the quantity of remaining oocytes in the ovarian follicle pool. 1, 2

Biological Basis

AMH is a polypeptide of the transforming growth factor beta (TGFβ) family that is solely secreted by granulosa cells of pre-antral and small antral ovarian follicles 1. This exclusive production site makes it a direct marker of the growing follicular pool 3.

Physiological Function

  • AMH inhibits the recruitment of primordial follicles from the resting oocyte pool, acting as a "follicular gatekeeper" that limits follicle growth initiation 1, 2
  • AMH suppresses follicle-stimulating hormone (FSH) action, contributing to the regulation of follicular development 1
  • AMH reflects continuous non-cyclic growth of small follicles, thereby mirroring the size of the resting primordial follicle pool 4

Clinical Applications

Ovarian Reserve Assessment

  • AMH correlates strongly with antral follicle count (AFC) and represents the best endocrine marker for assessing age-related decline of the ovarian pool 4, 3
  • AMH levels peak in the early-to-mid 20s and then decline progressively until menopause 2, 3
  • Median AMH values drop below 1.2 ng/mL by age 36, with the prevalence of diminished ovarian reserve (DOR) increasing from 15.9% at age 18 to 96% at age 45 5

Fertility Prediction

  • Low AMH levels (<1 ng/mL) are independently associated with reduced chance of natural conception (adjusted hazard ratio 0.77,95% CI 0.64-0.94) compared to normal levels (1-5.5 ng/mL) 6
  • AMH can predict ovarian response to hyperstimulation for IVF, identifying both poor responders and those at risk for ovarian hyperstimulation syndrome 2, 4
  • AMH has potential ability to predict future reproductive lifespan and timing of menopause, though marked variability exists 2, 3

PCOS Diagnosis

  • Serum AMH levels are significantly higher in women with PCOS compared to normal ovulatory women 1
  • AMH could serve as a surrogate marker for polycystic ovarian morphology (PCOM), potentially replacing ultrasound follicle counts in diagnosis 1, 2
  • The elevation in PCOS reflects both increased numbers of small antral follicles and intrinsic characteristics of granulosa cells 2

Post-Treatment Monitoring

  • AMH can assess iatrogenic damage to ovarian follicle reserve following chemotherapy or ovarian surgery 2, 3
  • AMH is used for surveillance of ovarian function in childhood cancer survivors, with most clinicians beginning surveillance 12-23 months after therapy completion 7

Important Limitations and Caveats

Technical Considerations

  • No international standard for AMH exists, leading to variability between assays and limiting comparability of results across studies 1, 2, 4
  • AMH assays display differential responses to pre-analytical proteolysis, conformational changes, and interfering substances 1
  • Appreciable sample-to-sample variability and substantial discrepancies in between-assay conversion factors indicate ongoing assay performance issues 1

Biological Variability

  • AMH shows limited short-term variability but is not completely stable throughout the menstrual cycle as previously thought 2, 8
  • Prolonged oral contraceptive use can influence AMH levels and should be considered in clinical assessment 2
  • AMH only reflects the growing follicular pool responsive to gonadotropins, not solely the underlying primordial pool 8

Clinical Context

  • AMH varies across the lifespan with complex dynamics during childhood and adolescence that differ from the straightforward decline in later reproductive years 2
  • Very limited data exist on relationships between AMH and natural fertility at different stages of reproductive life 2
  • Widespread clinical application requires standardization of when to obtain AMH and how to interpret results, as current practices vary significantly by specialty 7

References

1
Guideline

anti-müllerian hormone in pcos: a review informing international guidelines.

Trends in Endocrinology and Metabolism, 2019

4
Research

The role of anti-Müllerian hormone in female fertility and infertility - an overview.

Acta obstetricia et gynecologica Scandinavica, 2012

8
Research

The role of anti-müllerian hormone (AMH) in assessing ovarian reserve.

The Journal of clinical endocrinology and metabolism, 2011

Related Questions

What does a low anti‑Müllerian hormone (AMH) level of 0.16 ng/mL (previously <0.1 ng/mL) indicate for a 37‑year‑old woman's ovarian reserve and fertility?
What are the implications and management options for a 44-year-old female with an anti-mullerian hormone (AMH) level of zero?
What does a high anti-mullerian hormone (AMH) level of 9.88 indicate?
What does a high Anti-Mullerian Hormone (AMH) level of 8.91 indicate in a female?
What does anti‑Müllerian hormone (AMH) indicate about ovarian reserve?
What are the side effects of excessive vitamin D supplementation?
In a typical adult presenting with mild, non‑specific symptoms such as mild chest discomfort, transient headache, or anxiety and no red‑flag findings, is reassurance alone sufficient?
How many Saxenda (liraglutide) pens should be prescribed for a 28‑day regimen of 0.5 mg daily for 7 days followed by 1.2 mg daily for the remaining 21 days?
Can ezetimibe (Zetia) cause tachycardia?
What is the most likely cause and appropriate workup and treatment for a patient with low hematocrit, low mean corpuscular volume, low mean corpuscular hemoglobin, and elevated red cell distribution width (RDW‑CV)?
In a 70-year-old woman, how long is postoperative pain expected to last after a robotic femoral hernia repair?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question